Experience

• • One Rock Capital Partners in the formation of One Rock Capital Partners III, a $2 billion U.S. buyout fund.
  • Allergan in its $639 million acquisition of Vitae Pharmaceuticals, a clinical-stage biotechnology company.
  • Avanath Capital Management in the formation of Avanath Affordable Housing IV, a $760 million U.S. real estate fund.
  • Arroyo Energy Investors in the formation of Arroyo Energy Investors Fund II, a $360 million North America and South America power/energy fund.
  • Clayton, Dubilier & Rice in the formation of agilon health, a new healthcare technology and services platform, through the acquisition and merging of Primary Provider Management and Cyber-Pro Systems.
  • HarbourVest Partners as lead buyer in a GP-led tender for LP interests in Heritage Healthcare Innovation Fund and a related commitment to Heritage Healthcare Innovation Fund III.
  • HarbourVest Partners in various fundraisings, including the formation of:
  • HarbourVest Partners XI, a $2.6 billion global investment program.
  • HarbourVest Partners Co-Investment Fund IV, a $1.75 billion global buyout/growth equity fund.
  • HarbourVest 2017 Global Fund, a $354 million global fund of funds.
  • Kelso & Company in the formation of Kelso Investment Associates X, a $2.75 billion U.S. buyout fund.
  • Providence Equity Partners in its acquisition from General Motors and Ford of a majority stake in OEConnection, the established market leader in cloud-based technology solutions that facilitate the efficient location, sale, distribution and dynamic pricing of automotive parts.
  • Oaktree Capital Management in various fundraisings, including the formation of:
  • Oaktree Opportunities Fund X/Xb, a $12.5 billion global distressed debt fund.
  • Oaktree Principal Fund VI, a $1.2 billion global distressed fund.
  • Oaktree Mezzanine Fund IV, an $852 million North America mezzanine fund.
  • Odyssey Investment Partners in the formation of Odyssey Investment Partners Fund VI, a $3.25 billion North American buyout fund.
  • StepStone Group as lead investor in the $670 million closing of Ampersand Continuation Fund, together with related investment vehicles, formed to acquire the equity interests of three portfolio companies previously held by multiple mature Ampersand funds.
  • Vinci Partners in the formation of Vinci Capital Partners Fund III, a $1 billion private equity fund program.